Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and bms 536924

pyrroles has been researched along with bms 536924 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garcia-Echeverria, C1
Sun, W; Wang, GS; Xu, LB; Xu, Y; Yang, XH1
Ballot, J; Browne, BC; Crown, J; Duffy, MJ; Eustace, AJ; Kennedy, J; Kennedy, S; Larkin, A; Madden, S; Mahgoub, T; McDermott, MS; O'Brien, NA; O'Donovan, N; Pedersen, K; Sclafani, F1
Chang, AY; Wang, M1

Reviews

1 review(s) available for pyrroles and bms 536924

ArticleYear
[Progress in the studies on small molecule IGF-1R inhibitors].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2008, Volume: 43, Issue:10

    Topics: Animals; Apoptosis; Benzimidazoles; Catechin; Cell Line, Tumor; Humans; Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction

2008

Other Studies

3 other study(ies) available for pyrroles and bms 536924

ArticleYear
Medicinal chemistry approaches to target the kinase activity of IGF-1R.
    IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:6

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Benzimidazoles; Drug Evaluation, Preclinical; Humans; Neoplasms, Experimental; Podophyllotoxin; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Tyrphostins

2006
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours.
    Breast cancer research and treatment, 2012, Volume: 136, Issue:3

    Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytoplasm; Female; Humans; Middle Aged; Molecular Targeted Therapy; Phosphorylation; Protein Kinase Inhibitors; Pyridones; Pyrimidines; Pyrroles; Receptor, ErbB-2; Receptor, IGF Type 1; Trastuzumab; Treatment Outcome

2012
In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma.
    Anti-cancer drugs, 2013, Volume: 24, Issue:3

    Topics: Alanine; alpha-Fetoproteins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Hepatocellular; Cetuximab; Dasatinib; Doxorubicin; Drug Screening Assays, Antitumor; Epothilones; Gefitinib; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperidines; Pyridones; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; Triazines

2013